• SPX
  • $5,970.37
  • 0.36 %
  • $21.66
  • DJI
  • $44,221.46
  • 0.8 %
  • $351.10
  • N225
  • $38,283.85
  • 0.68 %
  • $257.68
  • FTSE
  • $8,262.08
  • 1.38 %
  • $112.81
  • IXIC
  • $19,014.04
  • 0.22 %
  • $41.62
Adicet Bio, Inc. (ACET) Stock Price, News & Analysis

Adicet Bio, Inc. (ACET) Stock Price, News & Analysis

Currency in USD Disclaimer

$0.91

-$0

(-0.05%)

Day's range
$0.91
Day's range
$0.95
50-day range
$0.91
Day's range
$1.57
  • Country: US
  • ISIN: US0070021086
52 wk range
$0.91
Day's range
$3.77
  • CEO: Mr. Chen Schor BA, CPA, M.B.A.
  • Website: Visit Site


We are preparing, please wait

Analyst Ratings

Key Stats

Key stats represent essential financial metrics and indicators used to evaluate a company's performance and potential investment opportunities.

Stock Score/grades

The Stock Score/Grades evaluate bankruptcy risk and assess the financial strength and fundamental health of a company

  • Altman Z Score -1.90
  • Piotroski Score 3.00
  • Grade Buy
  • Symbol (ACET)
  • Company Adicet Bio, Inc.
  • Price $0.91
  • Changes Percentage (-0.05%)
  • Change -$0
  • Day Low $0.91
  • Day High $0.95
  • Year High $3.77

Adicet Bio, Inc., a biotechnology company, discovers and develops allogeneic gamma delta T cell therapies for cancer and other diseases. The company offers gamma delta T cells engineered with chimeric antigen receptors and T cell receptor-like antibodies to enhance selective tumor targeting, facilitate innate and adaptive anti-tumor immune response, and enhance persistence for durable activity in patients. Its lead product in pipeline includes ADI-001, which is in Phase I clinical study for the treatment of non-Hodgkin's lymphoma. The company also engages in the development of ADI-002, which is undergoing preclinical studies for the treatment of various solid tumors. Adicet Bio, Inc. is based in Boston, Massachusetts.

  • Last Earnings 09/06/2018
  • Ex-Dividend for 5/16 Dividend 09/21/2018
  • Dividend Payable 10/09/2018
  • Today N/A
  • Next Earnings (Estimated) 03/12/2025
  • Fiscal Year End N/A

  • Average Stock Price Target $32.50
  • High Stock Price Target $38.00
  • Low Stock Price Target $27.00
  • Potential Upside/Downside N/A
  • Consensus Rating Sell
  • Rating Score (0-4) N/A
  • Research Coverage N/A

  • EPS (Most Recent Fiscal Year) -$2.94
  • Trailing P/E Ratio -0.46
  • Forward P/E Ratio -0.46
  • P/E Growth -0.46
  • Net Income $-142,658,000

Income Statement

Quarterly

Annual

Latest News of ACET

The Latest News section aggregates recent news posts from various news outlets, offering a comprehensive overview of the most recent developments related to the topic.

Enter your phone number to get Breaking News Updates

Stay ahead with instant updates! Enter your phone number for breaking news alerts, ensuring you're always in the know with the latest developments.


We are preparing, please wait

Adicet Bio, Inc. Frequently Asked Questions

  • What were the earnings of ACET in the last quarter?

    In the last quarter Adicet Bio, Inc. earnings were on Wednesday, November, 6th. The Adicet Bio, Inc. maker reported -$0.34 EPS for the quarter, beating analysts' consensus estimates of -$0.36 by $0.02.

  • What is the Adicet Bio, Inc. stock price today?

    Today's price of Adicet Bio, Inc. is $0.91 — it has decreased by -0.05% in the past 24 hours. Watch Adicet Bio, Inc. stock price performance more closely on the chart.

  • Does Adicet Bio, Inc. release reports?

    Yes, you can track Adicet Bio, Inc.'s financials in yearly and quarterly reports directly on Stocks.News.

  • What is the Adicet Bio, Inc. stock forecast?

    Watch the Adicet Bio, Inc. chart and read a more detailed Adicet Bio, Inc. stock forecast to see what analysts suggest you do with its shares.

  • What is Adicet Bio, Inc. stock ticker?

    The stock ticker can vary on the respective exchange. For instance, on NASDAQ, exchange stock trades by Adicet Bio, Inc. stock ticker.

  • How to buy Adicet Bio, Inc. stocks?

    Like other stocks, ACET shares are sold on stock exchanges such as NASDAQ. The best way to obtain them is through an online stock broker. Open an account, follow the broker's steps, and start trading.

  • What is Adicet Bio, Inc.'s EBITDA?

    Adicet Bio, Inc. measures a company's operating performance, and its growth indicates efficiency improvements. Access more stats in Adicet Bio, Inc.’s financial statements.

  • What is the Adicet Bio, Inc.'s net income ratio for the financial year 2023?

    The net income ratio for the financial year 2023 is 0, which equates to approximately 0.00%. This ratio indicates the percentage of net income generated from total revenue and serves as a key measure of a company’s profitability.

  • Should I invest in Adicet Bio, Inc. stocks?

    Investing in stocks requires thorough research. Carefully examine all available data, including Adicet Bio, Inc.'s financials relevant news, and technical analysis. Adicet Bio, Inc.'s technical analysis shows a “buy” rating today and a one-week “buy” rating. Since market conditions can change, it’s wise to look at longer-term trends — the one-month rating for Adicet Bio, Inc. stock currently indicates a “sell” signal. For more insights, review Adicet Bio, Inc.’s technical analysis.

Portfolio Sync Solutions

Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced

GET STARTED
Portfolio Sync Solutions
×
New Alert

Select an alert type

Choose sentiment spike or mentions spike or both to receive email alerts and app notification for the selected stock.
Note: Please be aware that you will receive an email only once a day, around 8:00 AM (EST), in the event of any spike.
In future if you don't want to receive any email then delete stocks added into alert section.

New Alert

Setup alert

×

Premium Content

This content is only available for premium members. Please become a paid member to access.

Download App

Currently, memberships can only be purchased through the app.

×

Log In


or

download app using google store Continue with Google download app using apple Continue with Apple

Email Verification

An email with a verification code has been sent to your email address.

Welcome to Stocks.News!

Create Your Account

Email Verification

An email with a verification code has been sent to your email address.